Moody's Ratings (Moody's) has completed a periodic review of the ratings of Synthomer plc and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 7 February 2025 in which we reassessed the appropriateness of the ratings in the context of t...
In this publication, we review the past year and discuss our outlook for the next 12 months. We begin our discussion with the macro factors at play, including GDP forecasts, the geopolitical landscape and our expectations for cost inflation. We also trace the development of primary markets in the European HY space, and give our view on defaults in general as well as for our coverage universe. We then discuss sector trends and expectations, along with earnings development for companies under our ...
In today's Morning Views publication we comment on developments of the following high yield issuers: SPIE, Teva, Digi Communications, Altice France (SFR), Telenet, Sunrise, Air France-KLM, Axactor, Victoria, Ineos, Stada, Oriflame, Casino Guichard-Perrachon, Boparan, Synthomer, NewDay
Moody's Ratings (Moody's) assigned a B1 rating to Synthomer plc's (Synthomer, the group or the company) proposed backed senior unsecured note issuance (the new notes) for an amount up to €350 million and a tender offer with a maximum acceptance of €370 million. The existing B1 long-term corporate f...
Moody's Ratings (Moody's) has today downgraded Synthomer plc's (Synthomer) long-term corporate family rating (CFR) to B1 from Ba3 as well as its probability of default rating (PDR) to B1-PD from Ba3-PD. Concurrently Moody's downgraded the rating on its €520 million backed senior unsecured notes to B...
A director at Synthomer bought 10,000 shares at 185p and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing ...
Moody's Investors Service (Moody's) has today downgraded Synthomer plc's (Synthomer) long term corporate family rating (CFR) to Ba3 from Ba2, as well as its probability of default rating (PDR) to Ba3-PD from Ba2-PD. Concurrently Moody's downgraded the rating on the €520 million backed senior unsecur...
Moody's Investors Service (Moody's) has today downgraded Synthomer plc's (Synthomer) long term corporate family rating (CFR) to Ba3 from Ba2, as well as its probability of default rating (PDR) to Ba3-PD from Ba2-PD. Concurrently Moody's downgraded the rating on the €520 million backed senior unsecur...
The independent financial analyst theScreener just requalified the general evaluation of SYNTHOMER (GB), active in the Speciality Chemicals industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date January 18, 2022, the...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.